KAPA
AMEXKairos Pharma, Ltd.
Healthcare · Biotechnology
Price History
Learn Why It Moved
Educational concepts related to this stock
Low Float
This stock has a relatively low number of shares available for trading, which can amplify price movements.
Volume Surge
Unusual trading volume indicates heightened interest — institutional activity or news-driven demand.
Selling Pressure
A significant downward move. Understanding risk management and stop losses is critical here.
Biotech Catalyst
Biotech stocks are often driven by FDA approvals, trial results, and regulatory news. Learn how binary catalysts work.
Insider Activity
Check if insiders have been buying or selling. Insider buying is one of the strongest signals in small cap trading.
Dilution Risk
Check SEC filings for active shelf registrations. Dilution is the #1 risk in small cap trading.
Kairos Pharma, Ltd. operates as a clinical-stage biopharmaceutical company focused on developing innovative treatments for individuals battling cancer. Its therapeutic portfolio includes a range of antibodies and small molecules engineered to combat various malignancies, such as prostate, lung, and breast cancer, as well as glioblastoma. Initially incorporated in 2013 under the name NanoGB13, Inc., the enterprise officially adopted its current identity as Kairos Pharma, Ltd. in July 2016. The company's operations are headquartered in Los Angeles, California.